ASCT Page 1 of 8 · 2008. 12. 2. · For consideration, please forward your resume to: Cathy...

ASCT Executive Council

President – Brent Brewerton President-Elect – Lynnette Savaloja Treasurer– Joan Rossi Immediate Past President–Kalyani Naik Legislative Consultant – Janie Roberson

Regional Directors Region1 – Dan Cybula Region 2 – Don Schnitzler Region 3 – Don Simpson Region 4 – Beth Ujevich Region 5 – Joe Walker

Editorial Board Editor in Chief -- Brenda Schultz Stoughton, WI Editorial Assistant -- Beth Denny Raleigh, NC Education Editor -- Barbara Frain Indianapolis, IN Legislative Affairs Editor -- Janie Roberson Birmingham, AL Professional Standards Editor -- Lynnette Savaloja St. Paul, MN E-Newsletter Designer -- Nancy Difede Raleigh, NC Region Spotlight Editor -- Jean Taylor

Publication Schedule

Volume IV Editorial Deadline Issue 4 June 2, 2007 Mid-July available on line Issue 5 August 1, 2007

November 2007

The American Society for Cytotechnology, as the collective voice for the profession, is committed to defining and promoting

the profession of Cytotechnology

The Committees of ASCT… The Fast Track to Becoming Involved

by Brenda Schultz Editor-in-Chief, the Voice

It’s not a secret that many representatives of our organization have been involved for a number of years. We just cannot get them to leave! But all kidding aside, we have found that once members find their passion, they usually stay around because of the unique and fun experience. They also possess a sense of fulfillment as they contribute to their profession. For most, this experience and opportunity begins when they join a committee. No member is denied the opportunity to join a committee within the ASCT. The only requirement is that members come prepared to contribute. This issue of the Voice shares an overview of the current committees of the ASCT and introduces the membership to the current Committee Chairs. If you are interested in joining or obtaining more information (we hope you are) you can contact the Committee Chairs directly, an Officer or the ASCT Central office.

Click here for More>>The Committee: Education

Click here for More>>The Committee: Public Relations

of 8ASCT

11/6/2007http://www.asct.com/newsletter/nov07/menupage.html

Mid-September available on line Issue 6 October 1, 2007 Mid-November available on line Volume V Editorial Deadline Issue 1 December 1, 2007 Mid-January, 2008 available on line

Issue 2 February 2, 2008 Mid-March, 2008 available on line

Issue 3 April 1, 2008 Mid-May, 2008 available on line

ASCT

1500 Sunday Drive Suite 102 Raleigh , NC 27607 800-948-3947 phone 919-787-4916 fax

www.asct.com

For the Voice in its entirety (.pdf), please click here...

by Sandy Giroux Public Relations Chair

In August 2007, I completed by 29th year of service at Fletcher Allen Health Care (FAHC) in Burlington, Vermont, my first and only cytology position! Thirty years ago I relocated from Manhattan to attend the Cytology Program at the Medical Center Hospital of Vermont which over time evolved into FAHC. When I started the program I was planning on looking for employment somewhere in New England never knowing that I would be staying in Vermont much longer than the one year internship. Meeting my future husband, Ron was also an incentive to stay in Vermont. I worked as a staff cytotechnologist for 3 years, cytology supervisor for 4 years before becoming the School of Cytotechnology’s Program Director. At that point I had come full circle by taking the directorship of the program that I had originally attended. This brought me great professional satisfaction. Since then I earned my Masters’ Degree in Administration and have graduated over 100 students (no wonder I’m tired)!

Click here for More>>The Committee: Professional Standards and Practices

by Amy Wendel

Professional Standards and Practices Chair It is an honor to be a serving as the chair of the Professional Standards and Practice Committee for the ASCT. I see my role as an opportunity to serve fellow-colleague cytotechnologists. I feel especially privileged to be involved in our ever-changing profession, heeding your concerns and working together towards innovative solutions.

Click here for More>>The Committee: Membership

of 8ASCT


Marty Boesenberg, Membership Co-chair

I have been active in ASCT since the beginning of the society and have always felt that it is a vital voice in the medical community. I have been very proud of ASCT’s reputation for serious consideration and useful commentary on events and ideas that are important to the working cytotechnologist.

I have served as Regional Director twice, President once and Membership chair through at least three terms. I am pleased to be working with a co-chair this time and look forward to turning the reins over to Michelle Halstead. She has fresh ideas and the perspective of a much younger cytotech. I think she be a wonderful asset to connect ASCT with our new graduates and all of the professional community.

Click here for More>>The Committee: Annual Meeting

by Jill Caudill Annual Meeting Chair

Duties – Set the agenda for the annual meeting.

Pluses about the job – You get to work with fantastic people as you set up speakers and topics.

Minuses – looming deadlines and playing phone and email tag with very busy folks.

What you might want to know – the agenda is set somewhere between September and November 1 – so if you have thoughts and ideas – communicate that with the chair as soon as you can.

Click here for More>>The Committee: Long Range Planning

by Debbie Hillsdon-Smith, Long Range Planning Chair

I have been actively engaged in the field of cytology for a number of years in various roles as a cytotechnologist and in management. I have served in various volunteer positions in professional societies such as my current role as the Chair for the long range planning committee for ASCT. I have also

of 8ASCT


worked with ASCT Services, Inc. in the Chair and Secretary roles for a number of years to improve the business structure and policy. Past responsibilities for the ASCT have included committee member positions for Professional Standards and Practices and Public Relations. I like working with the ASCT because involvement has been an opportunity to support and encourage others while learning new skills and meeting new people with similar interests and goals for the field of cytology. It has been a rewarding experience to see the changes in the field and work with so many unique and talented individuals. I encourage others to get involved!

Click here for More>>What is NCD Day?

May 13 - National Cytotechnology Day 2007 Winner, Vicki Schneider, CT(ASCP)

To commemorate Dr. George Papanicolaou's contributions to the field of medicine, May 13 - his birthday - has been designated National Cytotechnology Day (NCD). The idea for NCD was first entertained and pursued at the ASCT Interim meeting in Atlanta, Georgia back in 1984 by ASCT member Bruce Buschmann. History was made the following year in Philadelphia, PA when the week of May12-18, 1985 became the first ever National Cytotechnology Week. The presentation of the proclamation, given by then Mayor of Philadelphia, W. Wilson Goode, was attended by Past ASCT President, Shirley Greening. Many local celebrations, mayoral and gubernatorial proclamations followed as NCD events grew in popularity.

DESIGN CONTEST National Cytotechnology Day 2008 WINNER TO RECEIVE $100 CASH

Submit design and slogan by February 8, 2008 Entries should be submitted to: Nancy Yockel, NCD Chairman

PO Box 1573 Bethany, OK 73008

[email protected] Click here for More>>

Spotlight on Region 3: Get Jazzed About New Orleans in 2008

of 8ASCT


by Don Simpson

Irvin Mayfield, a world-traveling jazz performer and cultural ambassador for New Orleans and Louisiana once stated that, “jazz is improvising, developing themes, motifs and ideas.” Analogous to the evolving practice of cytology, the challenge for jazz musicians is to take what you’ve got and make something better out of it. You come up with individualistic ideas, yet you have to leave enough space so others can come up with their own ideas and do it together at the same exact time or it doesn’t sound good.

Click here for More>>Classified Ads Bench Cytotech Pendleton, Oregon

Bench Cytotech for rural Oregon Community. Ability to screen 70-80 conventional and liquid base slides per day. Nongyn slide screening preferred but not necessary. Salary DOE, excellent benefits. Full and part time positions considered. Please respond on line to [email protected]

Cytotechnologist, Florida Salary: Very Competitive Sign-on Bonus: Available Relocation: Some Assistance Essential Duties and Responsibilities: State of the art facility in comfortable office environment. Small, growing, physician owned IL. Duties include screening, quality assurance, some cyto prep, procedure development and regulatory compliance. Mostly non gyn and FNAs. The addition of new clients to this growing lab will keep this position interesting and challenging. You will supervise 2 – 3 part time cyto techs. Quality focused with attention to detail, organized, independent, able to analyze data, present technical findings, advise subordinates. CT ASCP required. FL license or eligible. Familiarity with requirements of CAP Accreditation. For consideration, please forward your resume to: Cathy Witherspoon President & CEO Witherspoon & Dowling, LLC 2 Birchleaf Lane Greer, SC 29650 (864) 268-2189 Office (864) 268-2191 Fax (888) 292-2189 Toll Free (864) 346-9919 Cell [email protected] www.witherspoonanddowling.com "Finding Tomorrows Success Today!"

Cytotechnologist, Florida

of 8ASCT


State of the art facility in comfortable office environment. Small, growing, physician owned IL.

Duties include screening, quality assurance, some cyto prep, procedure development and regulatory compliance. Mostly non gyn and FNAs. The addition of new clients to this growing lab will keep this position interesting and challenging. You will supervise 2 – 3 part time cyto techs.

Quality focused individual with attention to detail, organized, independent, able to analyze data, present technical findings, and advise subordinates. Familiarity with requirements of CAP Accreditation. CT ASCP and FL license required or eligible.

Dennis Wierck, SPHR Human Resources Manager

Reliance Pathology Partners, LLC 5747 Hoover Blvd Tampa, FL 33634

Ph 813-886-8334 Fx 813-885-6352

[email protected]

Cytotechnologist/CT1 –Cytology Laboratory – 1275 York Ave., NYC Microscopically examines preparations for cytologic evaluation, correlating clinical information with morphologic findings to make a final diagnosis on negative gynecologic slides and render a microscopic assessment on abnormal gynecologic and all non-gynecologic specimens pending diagnosis by a pathologist. We require: Bachelor’s or Master’s degree and CT(ASCP) certified or eligible. Must meet the requirements for the New York State Clinical Laboratory Technologist Licensure. Must meet the requirements for the New York State Department of Health Cytotechnologist Registration. Excellent computer, verbal and written communication skills. Hours: 9:00AM-5:00PM, Monday-Friday Please apply at www.mskcc.org using reference # 013890

Cytotechnologist California

Busy, independent lab seeks FT cytotechnologist to screen and evaluate a varied and interesting range on Non-GYN and GYN specimens. GYN specimens are both liquid based and conventional. Experience with CYTYC Imager is a plus. Must be ASCP certified with current California license. Salary based on experience. Excellent benefits. Please visit our website at www.dpmginc.com

Apply with resume to AP Fax: 916-446-5627 A Career in Cytotechnology: One Life-Long Cytotechnologist’s Report, Part 2

of 8ASCT


by Barbara McGahey-Frain, with Joanna Schoonover Joanna Schoonover, currently of Shaker Heights, OH, claims to be a retired cytotechnologist but in her “retirement” has been working for CompHealth and has had an opportunity to see many different parts of the United States. Having spent her entire career as a cytotechnologist, Joanna is frequently asked what her favorite “era” in this constantly evolving field has been…..her answer? “The most fun I have had in cytology is in the present.”

Click here for More>>Report from the CLIAC Meeting Sept. 5-6 2007

by Janie Roberson, Legislative Consultant The CLIA update included

CYTOLOGY Proficiency Testing NPRM

Revisions demanded by cytology community and supported by CLIAC CMS offered numerous opportunities to assist with compliance; listen educate and communicate CMS/CDC convened a special CLIAC Work Group and MeetingCMS collaborated with CDC to develop NPRM and it should be issued soon. Cytopathologist representatives proposed legislation that requires only coned in an attempt to derail CLIAC statutory provisions for individual PT

Pathologists without a cytotechnologist continue to fail at a greater rate than others. Failure rates for 06 are less than those for 05.

ASCT will be ready to present membership opinions both as an organization and assisting with individual responses when the Proposed Rule is issued.

Click here for More>>CMS Selects First Location for Clinical Laboratory Competitive Bidding Demonstration

of 8ASCT


Department of Health & Human Services Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Public Affairs Office MEDICARE NEWS FOR IMMEDIATE RELEASE Tuesday, October 16, 2007 The Centers for Medicare & Medicaid Services (CMS) today announced that it has selected the San Diego-Carlsbad-San Marcos, California metropolitan area as the first of two locations for a competitive bidding demonstration for clinical laboratory services provided to fee-for-service Medicare beneficiaries.

Click here for More>>Call for NominationsIf you’ve been wondering how you can make a difference in your profession, how you can have a voice in the issues that directly impact you…wonder no more! ASCT is what you’ve been looking for!

The ASCT Executive Council, the Society’s governing body, is made up of 5 Regional Directors, President, President-Elect, Treasurer and Legislative Consultant. ASCT is now seeking nominees for President-Elect and Region Directors of Regions 1,3 & 5 to continue leading the organization forward in its mission, as the collective voice for the profession, to define and promote Cytotechnology.

Click here for More>>2006 Consensus GuidelinesThe 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests the Management of Cervical Intraepithelial Neoplasia and Adenocarcinoma in situ* were published in the American Journal of Obstetrics and Gynecology (2007;197(4); 346-355) and are now available for review on the ASCCP website at http://www.asccp.org/consensus.shtml.

Click here for More>>Governor Signs Aanestad Medical Technology Bill SB 366 Results in Improved Health Care for California Patients

SACRAMENTO: Senate Bill 366 authored by Senator Sam Aanestad (R-Grass Valley) was recently signed into law by Governor Schwarzenegger. The measure will continue to allow California laboratories to follow workload requirements established by the federal Clinical Laboratory Improvement Amendments (CLIA), when gynecologic slides are reviewed with the use of state-of-the-art equipment and processes to detect cervical cancer.

Click here for More>>

of 8ASCT








The Committees of ASCT… The Fast Track to Becoming Involved

by Brenda Schultz Editor-in-Chief, the Voice

It’s not a secret that many representatives of our organization have been involved for a number of years. We just cannot get them to leave! But all kidding aside, we have found that once members find their passion, they usually stay around because of the unique and fun experience. They also possess a sense of fulfillment as they contribute to their profession. For most, this experience and opportunity begins when they join a committee. No member is denied the opportunity to join a committee within the ASCT. The only requirement is that members come prepared to contribute. This issue of the Voice shares an overview of the current committees of the ASCT and introduces the membership to the current Committee Chairs. If you are interested in joining or obtaining more information (we hope you are) you can contact the Committee Chairs directly, an Officer or the ASCT Central office.

The three STANDING COMMITTEES are: Nominations, Membership and Budget and Finance. The current AD HOC COMMITTEES are: ASCT Voice/Publications, Professional Standards and Practices, Legislative and Regulatory Affairs, Education, Public Relations, By Laws and Resolutions and the Long Range Planning Committee.

Nominations Committee

Chair: Chair Assumed by Immediate Past President Reports to: President Term of Service: 1 Year Chairperson: The chairperson of the nominations committee shall be the Immediate Past President of the ASCT. Responsibilities: The Nominations Chair is responsible for two (2) elections each year: the office of President-Elect and half of the regional directors.

The Nominations Chair shall encourage eligible candidates to run for office and local groups to nominate a regional director. The chairman shall submit a report to the Executive Council at the time of the annual meeting.

Membership Committee Reports to: President Chair: Appointed by President Term of Service: Chair term subject to appointment by

Page 1 of 8ASCT

11/6/2007http://www.asct.com/newsletter/nov07/art1.html




ASCT


www.asct.com


the President; Members subject to appointment by Chair and approval of the President Voting Privileges: No Committee: The membership committee consists of a committee chairperson and individual members. There is no limit to the number of members that make up this committee. All Regional Directors are ad hoc members of this committee. All committee members serve on the committee for one year.

Basic Duties: 1. Work with Management Office to develop and maintainrecruitment materials for use by regional directors and Executive Council. Recruitment material is subject to approval by the Executive Council, and review before distribution by Editor of the Publications Committee and Public Relations Chair. 2. Works with Management Office to maintain chart of the five geographic regions, numbers of members by region, and membership trends. 3. Directs the annual membership drive. 4. Assist regional directors in regional membership drives to maintain current membership and recruit new members and assist in pursuit of delinquent members. 5. Work with Education Committee to increase student membership. 6. Work with Public Relations Committee to review member information on website and in Members Only section. Review and add new topics to the discussion board. 7. Write bimonthly reports to the Executive Council.

Budget and Finance Committee

Chair: Assumed by the Treasurer Reports to: President and Executive Council Term of Service: Chair term concurrent with Treasurer position Members subject to appointment by Chair and approval of the President Voting Privileges: No Basic Duties:

1. Assists Treasurer to prepare an annual budget. 2. Presents the budget at the annual and interim meeting of the ASCT for approval by the Executive Council. 3. Consults with President on financial matters. 4. Prepares reports for: a. Executive Council

5. Receives and reviews non budgeted requests for projects, surveys, fund-raising, etc.

ASCT Publications Committee

Reports to: President and Executive Council Chair: The Voice Editor-in-Chief Editor/Chair: Subject to appointment by the President with approval by the Executive Council Voting Privileges: No Committee Members: Editorial Board of ASCT Voice

Page 2 of 8ASCT


Editor-in-Chief duties and responsibilities

1. Publishes ASCT Voice using information and articles gathered from the editorial board, regional directors, ASCT members and other cytology resources.

2. Seeks, develops, oversees and implements ideas for new publications with approval of the President.

3. Works with the Management Office to format and print ASCT Publications.

4. Insures publications are distributed on a regular and timely basis.

5. Approves final copy of all publications for format and accuracy.

6. Maintains regular contact with Editorial Board and Executive Council.

Legislative & Regulatory Affairs Committee

Reports to: President and Executive Council Chair: Assumed by the Legislative ConsultantTerm of Service: Chair Term concurrent with term of Legislative Consultant Members subject to appointment by legislative chair/legislative consultant and approval of the President Voting Privileges: No Consists of: Chairperson and a recommendation of at least three committee members.

Basic Functions:

1. Monitors and investigates all areas dealing with legislative and regulatory issues related to cytotechnologists and cytology testing.

2. Provides verbal or written reports on findings of these investigations to the executive council of the ASCT .

3. Provides written bi-monthly action reports to the Executive Council.

3. Under the direction of the president and Executive Council conducts surveys, writes articles for the ASCT Voice, and attends designated meetings to gather and disseminate information to the Executive Council and ASCT members, concerning legislative and regulatory issues related to cytotechnologists.

Professional Standards and Practices Committee

Reports to: President and Executive Council Chair: Appointed by President Term of Service: Chair subject to Appointment by the President Members subject to appointment by Chair and approval of the President Voting Privileges: No Consists of: Chair and a recommendation of at

Page 3 of 8ASCT


least three committee members.

Basic Functions:

1. Investigates and reviews all areas dealing with professional standards and practices of cytotechnologists to include but not limited to:

Quality Assurance Workloads Diagnostic Cytology Classifications and Reporting Methods Cytology Training Programs Cytology Registry and other Competency Examinations Federal Office of Personnel Management Standards Civil Service/Military Ratings of Cytotechnologists Ethics of Cytotechnologists Salaries for Cytotechnologists

2. Reports findings of these investigations or reviews to the executive council of the ASCT via written and verbal reports.

3. Under the direction of the president and executive council conducts surveys, Standing member of the publications committee, writes reports for the ASCT Voice on legislative and professional standards and practices issues,or attends designated meetings to gather and disseminate information to the executive council and ASCT members, concerning issues related to the professional standards and practices of cytotechnologists.

4. Write bimonthly reports to the Executive Council.

Education Committee

Reports to: President Chair: Appointed by President Term of Service: Chair term subject to appointment by the President; Members subject to appointment by Chair and approval of the President Voting Privileges: No Basic Duties:

1. Investigate effective, inexpensive means of continuing education for cytotechnologists.

2. Keep the membership informed through ASCT Voice of upcoming educational events.

3. Be aware of basic educational requirements including accredited programs and eligibility routes for ASCP Board of Registry certification examinations.

Page 4 of 8ASCT


4. Be aware of revisions that take place to basic educational requirements for becoming a cytotechnologist (Standards and Guidelines for the Accreditation of Educational Programs in Cytotechnology and Entry Level Competencies for the Cytotechnology Curriculum as developed by the Commission on Accreditation of Allied Health Education Programs (CAAHEP). Review changes, when they occur, develop comments, if necessary, and forward recommendations to President.

5. Write bimonthly reports to the Executive Council.

6. Write reports for the ASCT Voice concerning prior, as well as upcoming ASCT workshops.

7. Promote student participation in the Society via mechanisms such as "Student Interesting Case Competition" at Annual Meeting.

Public Relations Committee

Reports to: President Chair: Appointed by President Term of Service: Chair term subject to appointment by the President. Members subject to annual appointment by Chair and approval of the President Voting Privileges: No Basic Duties:

1. Promote the role of the cytotechnologist in the health care system.

1. Stimulate communication and cooperation among those persons actively engaged in the practice of diagnostic cytology and among cytotechnologists and other health care professionals.

1. Communicate:

a. Describe cytotechnology as a profession. b. Recruitment into the profession. c. Public education about pertinent cytology health related issues. d. Respond to all inquiries.

1. Writes bimonthly report distributed to Executive Council. Summarize activities.

1. Write annual report for The Voice

1. Solicit individuals from the general membership to participate in committee activities.

Page 5 of 8ASCT


1. Monitor, review and submit updates for ASCT website etc.

By-Laws and Resolutions Committee Chair: Appointed by the President Term: Chair term subject to Appointment by the President Members subject to annual appointment by Chair and approval of the President Voting Privileges: No Basic Duties: 1. Monitor By-Laws, recommending revision where deemed advisable. 2. Verify that all motions and actions of ASCT carry out the objectives of the organization as stated in the By-Laws, and when they do not, to inform the president so that appropriate action may be taken. 3. Recommend to the president to which committee or task force each resolution should go. 4. Present a written report to the executive council at the annual and interim meetings. 5. Responsible for maintaining and updating the ASCT Policy and Procedure Manual.

Annual Meeting Committee

Chair: Appointed by the President Reports To: President Term of Service: Chair term subject to appointment by the President Members subject to annual appointment by Chair and approval of the President Voting Privileges: No Committee: Chairman and a recommendation of at least three committee members.

Basic Functions: 1. Plan and organize Annual Meeting each year to include: developing scientific program and working with Education Committee to develop activities/sessions targeted for students. 2. Identify local organization/ society to partner with 3. Review data from previous years’ meetings and make recommendations to improve future meetings. 4. Plan meeting dates two years ahead and work with President, President-elect and management group to identify and secure location and date for following years annual meeting. 5. When researching possible meeting sites, select sites that will avail the ASCT of the least expensive overall meeting costs; airfares, hotel, meeting rooms, etc. 6. Work with management organization to develop and distribute registration form and handouts 7. Chair must identify at least one individual from committee and mentor him/her to take over as Chair when term expires so person will have experience.

Page 6 of 8ASCT


Meeting Time Table: 1. Annual Meeting: To be held during the month of March or April to not coincide with Easter or other holiday. 2. Interim Meeting: When deemed appropriate and finances allow and needed to carry on the business of the ASCT. Held on as needs basis at discretion of President and Treasurer.

*committee began in 2005-2006

Long Range Planning Committee

Chair: Appointed by the President Reports To: President Term of Service: Chair term subject to appointment by the President Members subject to annual appointment by Chair and approval of the President Voting Privileges: No Committee: Chairman and a recommendation of at least three committee members.

Basic Functions:

1. Monitor current strategic plan and goals and evaluate effectiveness of ASCT in meeting the plan

2. Evaluate current strategic plan and make recommendations to modify it with the goal of increasing financial stability and making it less dependent upon ASCT Services Inc

3. Review the ASCT mission statement and provide recommendations for modification if deemed appropriate

4. Monitor effectiveness of EC procedures and organizational structure and make recommendations to increase effectiveness.

5. Assist in developing educational materials and seeking need for new materials and what future needs may be.

Liaisons

Liaisons: CETC, JCAHO, CLIAC, ASC Reports To: President Term of Service: At discretion of President; Dependent upon Liaison Position Voting Privileges: No Basic Functions:

In general, liaisons

1. Maintain open communication between the two organizations and identify opportunities to work

Page 7 of 8ASCT


together on different tasks. 2. Respond to practice needs of members and cytology

community, establish and maintain on-going relationships with cytology societies, identify professional concerns, collaborate with national organizations.

3. Participate in conference calls and, upon prior approval, national meetings when necessary.

Selection of CETC liaisons:

Two members of the CETC are representatives of ASCT. In order to provide adequate representation, liaisons must be familiar with current ASCT practices, policies and positions. Towards that end, one of the two members should be a member of the Legislative Committee and one should be a member of the Professionals Standards and Practices Committee. The Legislative Consultant and Chair of Professional Standards Committee submit recommendations for the liaison positions to the President for review and approval.

Selection of JCAHO liaison:

One liaison is selected, usually from the Professional Standards and Practices Committee. The Chair of this committee submits a recommendation for the liaison position to the President for review and approval.

Selection of CLIAC liaison:

The Legislative Consultant serves as CLIAC liaison.

Selection of the ASC liaison:

The President serves as ASC liaison.

The ASC liaison to ASCT is appointed to the ASC. Upon agreement with ASC in 2005-06, the ASC liaison term will follow the ASCT fiscal year. During the transition period from ASC fiscal year to ASCT fiscal year, the current ASC liaison will serve until April 2007. The ASCT President should confirm appointment annually.

Back to the articles

Page 8 of 8ASCT








The Committee: Public Relations

by Sandy Giroux Public Relations Chair

In August 2007, I completed by 29th year of service at Fletcher Allen Health Care (FAHC) in Burlington, Vermont, my first and only cytology position! Thirty years ago I relocated from Manhattan to attend the Cytology Program at the Medical Center Hospital of Vermont which over time evolved into FAHC. When I started the program I was planning on looking for employment somewhere in New England never knowing that I would be staying in Vermont much longer than the one year internship. Meeting my future husband, Ron was also an incentive to stay in Vermont. I worked as a staff cytotechnologist for 3 years, cytology supervisor for 4 years before becoming the School of Cytotechnology’s Program Director. At that point I had come full circle by taking the directorship of the program that I had originally attended. This brought me great professional satisfaction. Since then I earned my Masters’ Degree in Administration and have graduated over 100 students (no wonder I’m tired)!

I am a true believer in the importance and value of volunteer work both in the professional and community arena. Locally, I am a member of the Junior League of Champlain Valley an all volunteer organization. Our community projects focus on the needs of children, families and women. Short-term projects have included renovating (transforming actually) the Children Playrooms at the Ronald McDonald Home and at the local Family Shelter from drab, uninviting, non-functional areas to bright, invigorating spaces with colorful paint, built in bookshelves, new curtains and of course new books and toys! Our long-term project is Camp Knock Knock in collaboration with the Visiting Nurse Association. It is a weekend camp for families with children who have experience the lost of a loved one. We seek to provide a safe environment for families who are experiencing the natural grieving process. Camp is a unique blend of age specific grief workshops and traditional camp activities such as camp fires, cook-outs and canoeing. Camp Knock Knock was named in honor of a delightful child and relentless purveyor of knock knock jokes who was cared for by the VNA. She died of a brain tumor in 1988 and we strive to honor her undaunted spirit and courage with our

Page 1 of 2ASCT





ASCT


www.asct.com


eleventh camp in 2008.

On the professional level I am currently actively involved in the ASCT, ASCP and the Vermont/New Hampshire Cytotechnology Association. In the past I have served on the ASC Cytotechnology Programs Review Committee for four years. I become more active within the ASCT two years ago when incoming president, Kalyani Naik asked me to become the Chair of the Annual Conference Planning Committee, for those of you who know Kalyani, you know it’s difficult saying “no” to her! And now I say, what took me so long? The ASCT is a greatorganization to work with, I am constantly impressed with the members’ professionalism, knowledge and devotion to our profession plus they’re fun! Currently I am the Public Relations (PR) Committee Chair; this committee is primarily involved with the oversight and continuous improvement of the ASCT website. Public Relations in regard to the newsletter and other publications is the responsibility of the Publications Committee. The PR committee currently consists of a total of 5 members including two of my recent graduates (it was hard for them to say “no”!). I encourage everyone to consider volunteering in your local community and for your local and national organizations. It may be time consuming at times but the benefits, results and being connected to your community and profession by far outweigh the investment.


Page 2 of 2ASCT








Committee Position: Professional Standards and Practices Chair

by Amy Wendel Professional Standards and Practices Chair

It is an honor to be a serving as the chair of the Professional Standards and Practice Committee for the ASCT. I see my role as an opportunity to serve fellow-colleague cytotechnologists. I feel especially privileged to be involved in our ever-changing profession, heeding your concerns and working together towards innovative solutions.

Mayo Clinic is my employer of choice. While at work, I keep engaged in the educationofour learner groups in Anatomic Pathology. Primarily, I serve as the educationcoordinator for our cytotechnology program. I am also our division of Anatomic Pathology’s education coordinator, providing continuing education and orientation venues for our consultants, residents, fellows and allied health staff. The newest addition to my role is serving as the Mayo Clinic technical site histology program director.

Details on my life (outside of work): newly married to my best friend, Eric, and a proud mama to a soft coated wheaten terrier (!), Paloehma Dolci. I am also finishing my Master’s degree in Education. We have a lot of fun around our house and we continue to make it our own… Some of my favorite past times include enjoying time with family and friends, gardening, exercising, traveling and cooking.

I have been a member of the ASCT since 2004 and I really appreciate that the ASCT is comprised of CTs working together for each other, as well as for the future of our valuable profession. Stay in touch!


Page 1 of 2ASCT








The Committee: Membership

Marty Boesenberg,

Membership Co-chair I have been active in ASCT since the beginning of the society and have always felt that it is a vital voice in the medical community. I have been very proud of ASCT’s reputation for serious consideration and useful commentary on events and ideas that are important to the working cytotechnologist.

I have served as Regional Director twice, President once and Membership chair through at least three terms. I am pleased to be working with a co-chair this time and look forward to turning the reins over to Michelle Halstead. She has fresh ideas and the perspective of a much younger cytotech. I think she be a wonderful asset to connect ASCT with our new graduates and all of the professional community.

My work has always been at Mercy Medical Center – Des Moines, where I was a CT for 15 years and then restarted the training program. I have combined two loves – cytotechnology and teaching – for the past 16 years! What a great job!

by Michelle Halstead

Membership Co-Chair

Hi. I am currently in my first year as a member of the ASCT. I think the most beneficial aspects of being a member are getting to know the other members, staying updated on the latest healthcare news in Washington and reading the ASCT newsletter publication "the Voice". Serving as the Co-Chair of

Page 1 of 2ASCT





ASCT


www.asct.com


the Membership Committee, I hope to continue to build on strengthening the communication between its members and find out how we can better serve our members. I highly encourage all cytotechnologists to become members of the ASCT and get involved as much as you can! I hope to meet as many of you as I can in the next annual meeting being held in Newport, RI. Outside of my professional endeavors, I enjoy working on my house, working in my yard and working on my cars. I enjoy taking things apart and putting them back together. The most recent addition to my yard project collection is a Husqvarna garden tractor. There is rarely a time when I don't have a project going on and many times it's several at the same time. There are so many things I want to learn and do!


Page 2 of 2ASCT








The Committee: Annual Meeting

by Jill Caudill

Annual Meeting Chair

Duties – Set the agenda for the annual meeting.

Pluses about the job – You get to work with fantastic people as you set up speakers and topics.

Minuses – looming deadlines and playing phone and email tag with very busy folks.

What you might want to know – the agenda is set somewhere between September and November 1 – so if you have thoughts and ideas – communicate that with the chair as soon as you can.

A little about me - I have been a cytotechnologist for 27 years, and I find that incredibly hard to believe. I honestly don’t feel that old. I have been an ASCT member for a very long time, I really can’t remember when I joined. Most of that time I was one of those members who didn’t really participate much. When the meeting was held in Minneapolis, Brenda Schultz asked me to present. I felt it was an incredible meeting, and I thought the size of the meeting was a perfect size for optimal interaction among professionals. Since then I have been more active, and when I was asked to chair this committee – I heartily agreed. I have a little experience putting agendas together; I organized the program faculty seminar for the American Society of Cytopathology for five years. This is a much larger scale, but I’ve had great help from Sue Zaleski – who I talked into assisting when she had a couple of ideas for me regarding our upcoming meeting in Newport, Rhode Island, April 4-6, 2008.

The job I get paid for – I’m the program director for the Cytotechnology Program at the Mayo Clinic in Rochester, Minnesota. I’ve held that job for 17 years (again, I really don’t feel that old). I love working with students, they keep me learning – which is what this profession is all about! I am very fortunate to work in such a wonderful facility, with great techs (many of whom have been my students) and

Page 1 of 2ASCT





ASCT


www.asct.com


pathologists.

A little personal information – I am originally from Louisville, Kentucky, but have moved around and lived in many places throughout my life. I received my Cytology education in Indianapolis, Indiana. My cytology jobs prior to my current position have been in Knoxville, Tennessee and Columbia, Missouri. I absolutely loved both places and the wonderful techs I worked with there. I don’t have children, but Jethro and Skeeter are my feline substitutes.


Page 2 of 2ASCT








The Committee: Long Range Planning

by Debbie Hillsdon-Smith, Long Range Planning Chair

I have been actively engaged in the field of cytology for a number of years in various roles as a cytotechnologist and in management. I have served in various volunteer positions in professional societies such as my current role as the Chair for the long range planning committee for ASCT. I have also worked with ASCT Services, Inc. in the Chair and Secretary roles for a number of years to improve the business structure and policy. Past responsibilities for the ASCT have included committee member positions for Professional Standards and Practices and Public Relations. I like working with the ASCT because involvement has been an opportunity to support and encourage others while learning new skills and meeting new people with similar interests and goals for the field of cytology. It has been a rewarding experience to see the changes in the field and work with so many unique and talented individuals. I encourage others to get involved!


Page 1 of 2ASCT








What is NCD Day?

May 13 - National Cytotechnology Day

2007 Winner, Vicki Schneider, CT(ASCP) To commemorate Dr. George Papanicolaou's contributions to the field of medicine, May 13 - his birthday - has been designated National Cytotechnology Day (NCD). The idea for NCD was first entertained and pursued at the ASCT Interim meeting in Atlanta, Georgia back in 1984 by ASCT member Bruce Buschmann. History was made the following year in Philadelphia, PA when the week of May12-18, 1985 became the first ever National Cytotechnology Week. The presentation of the proclamation, given by then Mayor of Philadelphia, W. Wilson Goode, was attended by Past ASCT President, Shirley Greening. Many local celebrations, mayoral and gubernatorial proclamations followed as NCD events grew in popularity. In addition to celebrating the important work of Dr. George Papanicolaou, NCD has been utilized as a means to promote the importance of the Pap test in women's health and the contributions of cytotechnologists to the health care field. Each year ASCT promotes NCD by hosting an annual NCD Logo Design Contest. The winning logo is used on promotional products for cytotechnologists and laboratories to celebrate NCD. Visit asct.com and click on National Cytotechnology Day for past winners and more information.

Ways to celebrate National Cytotechnology Day in your lab The ASCT would like to share how labs celebrate NCD. Please send us photos, ideas and articles on how you celebrated NCD this year to [email protected]

Educate others in your laboratory, hospital and community about the work of Dr. George Papanicolaou and the importance of the Pap test Invite local high school and college students to your lab to inform them of a career in cytotechnology and

Page 1 of 2ASCT





ASCT


www.asct.com


what academic and technical requirements are necessary Make a poster or exhibit or provide a lab tour to educate others about what cytotechnologists do Get an official NCD proclamation from the governor or mayor§ Proudly wear t-shirts celebrating NCD Bake cookies decorated as various types of cells and share with colleagues Create and play games like Cytojeopardy with your staff - it's both fun and educational

DESIGN CONTEST

National Cytotechnology Day 2008 Submit design and slogan by February 8, 2008

Entries should be submitted to:

Nancy Yockel, NCD Chairman PO Box 1573

Bethany, OK 73008 [email protected]

The award will be mailed March 14, 2008, and the winning design acknowledged at the 2008 Annual ASCT Conference in Newport, Rhode Island, April 4-6, 2008.

Rules:

1. Design must be an original concept of the applicant 2. Artwork cannot be an advertising copyright or

reproduction of a trademark. 3. Design and slogan selected becomes the property of

ASCT and

Action Specialty, Co.

Principle winner cannot be a minor. All entries received after the February 8, 2008 deadline will not be accepted. All entries must be submitted with applicants name, address, E-mail and phone number.

WINNER TO RECEIVE $100 CASH


Page 2 of 2ASCT








Spotlight on Region 3: Get Jazzed About New Orleans in 2008

by Don Simpson

Irvin Mayfield, a world-traveling jazz performer and cultural ambassador for New Orleans and Louisiana once stated that, “jazz is improvising, developing themes, motifs and ideas.” Analogous to the evolving practice of cytology, the challenge for jazz musicians is to take what you’ve got and make something better out of it. You come up with individualistic ideas, yet you have to leave enough space so others can come up with their own ideas and do it together at the same exact time or it doesn’t sound good.

Professional societies likewise have to be a group and each member an individual simultaneously. Thus, the education opportunities of current and emerging topics in the field of cytopathology will be second to none in offerings, and everyone will find something of interest and applicability at the 2008 exchange of the Southern Association of Cytotechnologists, Inc. (SAC) scheduled to be held in the Crescent City.

Jazz was born out of a funeral. All early jazz songs are slow church songs played on the way to the graveyard. The first-line (the family of the deceased person and everyone close to them) stays behind. Everybody else (the second-line) joins in the jazz processional away from the graveyard. They celebrate the person going to a better place.

Think about the irony of that joy coming out of one of the most tragic experiences in life and consider, perhaps, that life is about what we do when the mourning happens. Jazz is a fundamental resource that serves as a tool for healing and rebuilding, economically, culturally, spiritually, and professionally.

The time is now for you to plan on taking your place in the “second-line” of this celebration during the 2008 SAC meeting scheduled for July 24th through 28th at the historic Hotel Monteleone in New Orleans and experience first-hand the rebuilding of a culture and a transformation of your career. For more information please visit the SAC website at http://www.sacpage.org.

Page 1 of 2ASCT





ASCT


www.asct.com


Other upcoming continuing education opportunities in the region include the 2008 spring meeting scheduled for mid-April at Loyola Medical School in Chicago, IL. For more information about this offering please contact Jan Nelson at [email protected]. For information about the spring meeting of the Oklahoma society please contact Regina De Maio at [email protected].

Dr. Dan Kurtycz from the University of Wisconsin at Madison recently spoke at the fall meeting of the Illinois society held September 14-15, 2007, and the 2nd Annual Symposium for Emerging Concepts in Cytopathology was held at the University of Arkansas for Medical Sciences (UAMS) in Little Rock, Arkansas. In addition to pathologists and cytotechnologists representing a four-state area, Michelle Jacobs and Amy Fulmer from Cytyc were in attendance. Topics covered and speakers were as follows:

Lymph Node FNA: The example of Lymphoma

Leonard Bloom, MPH, CT(ASCP) – University of Tennessee, Memphis, TN

Neurocytology

Murat Gokden, MD – UAMS, Little Rock, AR

Thyroid Cytopathology

Chien Chen, MD, PhD – UAMS, Little Rock, AR

Molecular Testing and Training Programs for Molecular Diagnostics

Keisha Brooks, MS, CT(ASCP) – University of Tennessee, Memphis, TN

The Molecular Cytopathology Laboratory

Julie Gregg, BS, SCT(ASCP) – Tulsa Medical Laboratory, Tulsa, OK

Meaningful Cytopathology: The Essence of Communication

Don Simpson, PhD, MPH, CT(ASCP)CM – UAMS, Little Rock,AR


Page 2 of 2ASCT








A Career in Cytotechnology: One Life-Long Cytotechnologist’s Report, Part 2

by Barbara McGahey-Frain, with Joanna Schoonover Joanna Schoonover, currently of Shaker Heights, OH, claims to be a retired cytotechnologist but in her “retirement” has been working for CompHealth and has had an opportunity to see many different parts of the United States. Having spent her entire career as a cytotechnologist, Joanna is frequently asked what her favorite “era” in this constantly evolving field has been…..her answer? “The most fun I have had in cytology is in the present.”

Joanna shared these engaging vignettes from her recent “assignments:” I went to northern Wisconsin at the peak of the fall season and enjoyed the beautiful colors in the northern woods. I went to New Hampshire to work and traveled around Maine and Vermont. I lived in Maine many years ago and I visited Bath, Maine where my daughter was born.

I worked in New York one summer in the Niagara Falls area and frequently went across the border into Canada for dinner and shopping at Niagara on the Lake.

Florida at Christmas time was very interesting. I saw a fabulous Christmas display at a little town called Mt. Dora.

I worked in Virginia where I went to see Jefferson’s home for the second time and toured the historic sites in the state. Also went to Walton’s Mountain (there is such a place).

Indiana was another tour. I worked near Chicago and took the train into the city. I enjoyed boat rides and tours that were offered. The Michigan Mile was an interesting place to shop.

I enjoyed a sled ride in northern Michigan in the dead of winter complete with a seven course meal cooked on a wood stove and served in a lodge in the middle of the woods.

Page 1 of 2ASCT





ASCT


www.asct.com


Nebraska was an interesting state. I saw lots of historic places there and the biggest railroad yard in the country. The trains were so much fun to watch. I loved the stories about how the little town of North Platte befriended the military people as they made their way by rail across the country during World War II.

Lucky me. I worked in Holland, Michigan when the “Tulip Festival” was going on. It was beautiful. The streets were lined with tulips.

North Carolina was lots of fun during the month of April. Wilmington beaches were not yet crowded with tourists, so I went to the beach every night after work.

Iowa had lots of interesting places to go. The Amana villages were amazing and historic. I followed the Lewis and Clark trail across Iowa and across the county as much as I could and saw the trail end at the ocean in Oregon.

I worked in northern California. The redwood trees and the Trinity Mountains were something I enjoyed. Also Mt. Shasta and Mr. Lassen were places where I loved to spend time.

I spent the most time in Oregon. I love the state and the people. Central Oregon is beautiful and there is nothing quite like the mountains and the high desert. The rugged coast of Oregon is a sight to behold and I spent many hours watching for whales. A part of my heart will always be in Oregon and the people I worked with were the finest people I have ever met. I was able to travel to neighboring states on weekends.

It it hadn’t been for cytology, I never would have experienced any of this, so I am forever grateful to my profession. I continue to meet people who are dedicated in this work and it has made a very enjoyable retirement for me.

Thank you, Joanna, for sharing these experiences! Back to the articles

Page 2 of 2ASCT








Report from the CLIAC Meeting Sept. 5-6 2007

by Janie Roberson, Legislative Consultant The CLIA update included

CYTOLOGY Proficiency Testing NPRM

Revisions demanded by cytology community and supported by CLIAC CMS offered numerous opportunities to assist with compliance; listen educate and communicate CMS/CDC convened a special CLIAC Work Group and Meeting CMS collaborated with CDC to develop NPRM and it should be issued soon. Cytopathologist representatives proposed legislation that requires only coned in an attempt to derail CLIAC statutory provisions for individual PT

Pathologists without a cytotechnologist continue to fail at a greater rate than others. Failure rates for 06 are less than those for 05.

ASCT will be ready to present membership opinions both as an organization and assisting with individual responses when the Proposed Rule is issued.

Other Topics included........

Electronic Health Records (EHR) is a major initiative of the Secretary of DHHS and Laboratories are the prototype GAO 06 CLIA report follow up- several initiatives to strengthen laboratory oversight. If you recall this report was very critical of CLIA oversight of laboratory accreditation. Oversight of Genetic Testing

Proficiency Testing Working Group-Current status of PT in the US Dr. Robert Rej chaired this committee. It is

Page 1 of 3ASCT





ASCT


www.asct.com


group developed to examine broad issues of PT, not specific for cytology or other areas of the lab. This is a separate group than the one working on Cytology PT issues. A few findings:

There is no single study-much less a body of publishedevidence which unequivocally demonstrates that participating in PT reduces the rate of errors in routine testing of patient specimens. (i.e. PT is just part of the QA activities of a laboratories, no direct link will likely be demonstrated.) Experience with PT unquestionably reduces PT failure rates. PT Complacency: There is no real incentive ($$$) for providers to change PT since it is working reasonably well and meeting the regulatory requirements for most sections of the lab.

Official minutes will be posted on the CLIA.gov website at a later date. http://www.phppo.cdc.gov/cliac

DRAFT AGENDA Clinical Laboratory Improvement Advisory Committee

Meeting Centers for Disease Control and Prevention Tom Harkin Global Communications Center

Atlanta, Georgia September 5-6, 2007

Wednesday, September 5, 2007 8:30 a.m. – 11:45 a.m.

• Introductions/Conflict of Interests • Food and Drug Administration (FDA) – Agency Update • Centers for Medicare & Medicaid Services (CMS) –

Agency Update • Centers for Disease Control and Prevention (CDC) – Agency

Update • CLIA Research Agenda – Introduction

11:45 a.m. – 1:00 p.m. Lunch 1:00 p.m. – 5:00 p.m.

• CLIA Research Agenda – Presentations and Committee Discussion

• Overview of 2007 Institute on Critical Issues in Health Laboratory Practice

• Committee Discussion • Public Comments

Thursday, September 6, 2007 8:30 a.m. – 12:00 p.m.

• Oversight of Genetic Testing – Introduction • Oversight of Genetic Testing – Presentations and Committee

Discussion 12:00 p.m. – 1:00 p.m. Lunch

1:00 p.m. – 3:00 p.m. • Oversight of Genetic Testing – Presentations and Committee

Discussion (cont.) • Introduction to Quality Management Systems for the Clinical

Laboratory • Committee Discussion/Wrap-Up

• Public Comments • Adjourn


Page 2 of 3ASCT








CMS Selects First Location for Clinical Laboratory Competitive Bidding Demonstration

Department of Health & Human Services Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Public Affairs Office MEDICARE NEWS FOR IMMEDIATE RELEASE Tuesday, October 16, 2007 The Centers for Medicare & Medicaid Services (CMS) today announced that it has selected the San Diego-Carlsbad-San Marcos, California metropolitan area as the first of two locations for a competitive bidding demonstration for clinical laboratory services provided to fee-for-service Medicare beneficiaries. The demonstration, which was mandated by the Medicare Modernization Act of 2003, is designed to determine whether competitive bidding can be used to provide laboratory services under Medicare Part B at fees below current Medicare payment rates, while maintaining quality and access to care. Medicare paid nearly $6.7 billion to clinical laboratories in 2006. “CMS is seeking to enhance its role as a prudent purchaser of clinical laboratory services, while maintaining a strong focus on beneficiary access and quality of care,” Acting CMS Administrator Kerry Weems said. “This demonstration uses market-based competition to increase efficiency in Medicare. In this demonstration, Congress is building on the experience of CMS demonstrations for durable medical equipment, which found that competitive bidding can reduce spending, while assuring access and quality.” A project Web page, a public project mailbox, and a project listserv will support ongoing, open communication with the public. CMS has shared the proposed design for the demonstration at various stages of its development with the public. Early in 2004, CMS held the first Open Door Forum (ODF) listening session, followed by another ODF to share the demonstration design report. On July 16, 2007, CMS held a third ODF to walk the public through the draft Bidder’s Package. In addition, the proposed demonstration design was described in an Initial Report to Congress, submitted on April 19, 2006. The demonstration will include laboratories providing services to beneficiaries enrolled in traditional fee-for-service Medicare and living in the demonstration area. Part B helps pay for medical services provided by laboratories, physicians, and

Page 1 of 3ASCT

11/7/2007file://C:\Documents and Settings\Nancy Difede\My Documents\FIRST POINT\ASCT\AS...




ASCT


www.asct.com


other practitioners and suppliers, and covers clinical laboratory tests with no cost-sharing by beneficiaries. A Bidders Conference is planned for October 31, 2007 in the San Diego-Carlsbad-San Marcos, California metropolitan area to help laboratories providing services to Medicare beneficiaries residing in the demonstration area understand the purpose of the demonstration project and how it will be implemented, as well as answer questions. Additional information is available at: http://www.cms.hhs.gov/center/clinical.asp (click on“Demonstration”)

Beneficiaries and their physicians who order laboratory tests will continue to have a choice among various laboratories competing with each other on the basis of service and quality. Multiple winners will be selected based on bid price, as well as quality, capacity, geographic coverage and other non-price criteria. In addition to the quality standards required by the Clinical Laboratory Improvement Amendments (which apply to all clinical laboratories), terms and conditions for participation in the demonstration will include performance measurement. Performance measures will include total, transport, and processing turnaround times; total turnaround time for STAT tests; reporting turnaround time for critical values and for public health notification; log-in error rates; and rates of lost specimens. CMS will continue collection of these measures throughout the demonstration to ensure the timely delivery of quality laboratory services. Currently, CMS sets payment rates for clinical laboratory services under Medicare Part B prior to the start of each year. Although laboratories compete for business on non-price elements, such as quality and service, laboratories do not compete regarding price because Medicare pays every laboratory the same pre-set amounts. Under the demonstration, CMS will pay one single competitively-set price for each test code, but non-winning laboratories will not be permitted to bill Medicare directly. The demonstration is designed to enable even the smallest local clinical laboratories, which are exempt from bidding, to continue to provide services to Medicare beneficiaries, as opposed to a “winner take all” approach favoring large national laboratories. A small laboratory is defined as one with less than $100,000 annual Part B revenue for demonstration tests to Medicare fee-for-service beneficiaries in the competitive bidding area. These small laboratories are not required to submit bids but will be paid the competitively set demonstration rates for demonstration tests otherwise paid under the Part B clinical laboratory fee schedule. At the First Open Door Forum (ODF) the laboratory community requested that CMS include the entire clinical laboratory fee schedule in the demonstration. As a result of this input, CMS modified the demonstration design and it will cover almost all laboratory tests provided to beneficiaries enrolled in the traditional Medicare program who reside in the demonstration area during the three-year demonstration period. The 303 test codes included in the demonstration represent about 99 percent of all tests paid for by Medicare Part B based on volume and revenue. A few tests were excluded from the demonstration by Congress, including

Page 2 of 3ASCT


Pap smears and colorectal cancer screening tests, as well as tests furnished by entities that had a face-to-face encounter with the patient, such as physicians testing for their own patients in a physician office laboratory, or hospital outpatient testing. Beneficiaries who travel outside the area during the demonstration period and require laboratory services will be able to get them from other laboratories in the United States. As is currently the case, laboratories may not bill Medicare beneficiaries for laboratory services covered under the Medicare program. In designing the demonstration, CMS focused on protecting access to quality laboratory services for all Medicare beneficiaries, including vulnerable groups. In response to public comment, laboratories providing services exclusively to beneficiaries entitled to Medicare because they have end-stage renal disease (ESRD) will not be required to bid. These laboratories will be paid the competitively set demonstration rates for demonstration tests otherwise paid under the Part B clinical laboratory fee schedule. However, tests that are paid as part of ESRD bundled payments are excluded from this demonstration. CMS is adopting the same approach for laboratories providing services exclusively to beneficiaries residing in nursing homes or receiving home health services. A notice describing the demonstration project, the first selected site,and the date and location of the Bidder’s Conference is on displaytoday at the Federal Register and will be published on October 17. The notice is available on the demonstration website at http://www.cms.hhs.gov/DemoProjectsEvalRpts/ downloads/2004 Demonstration Competitive_Bidding_Clinical_Laboratory_Services.pdf http://www.cms.hhs.gov/DemoProjectsEvalRpts/downloads/ 2004%20Demonstration%20Competitive _Bidding_Clinical_Laboratory_Services.pdf Questions about the demonstration can be answered by email to [email protected] or by calling 1-866-613-9348 toll free. Beneficiaries and physicians can call 1-866-613-9348 toll free to reportany problems beneficiaries may experience accessing quality laboratory services under the demonstration so appropriate action can be taken immediately.


Page 3 of 3ASCT








Call for Nominations

If you’ve been wondering how you can make a difference in your profession, how you can have a voice in the issues that directly impact you…wonder no more! ASCT is what you’ve been looking for!

The ASCT Executive Council, the Society’s governing body, is made up of 5 Regional Directors, President, President-Elect, Treasurer and Legislative Consultant. ASCT is now seeking nominees for President-Elect and Region Directors of Regions 1,3 & 5 to continue leading the organization forward in its mission, as the collective voice for the profession, to define and promote Cytotechnology.

Nominations are due December 21, 2007. Please send to ASCT, 1500 Sunday Drive, Suite 102, Raleigh, NC 27607.Phone: 800-948-3947 Fax: 919-787-4916 Email:

[email protected]

In addition to the Nomination Form, please include the following biographical data in form of a curriculum vitae: Name of Nominee, Professional Certification, Education, and Professional Experience. Also email a JPG photo of yourself.

ASCT President Elect

The primary function of the President-Elect is to prepare for the position of President. Upon conclusion of the one-year term as President-Elect, he/she will assume the position of President for one year and subsequently, Immediate Past President for one year. In order to be nominated for the position of President-Elect, candidates must have served at least one term as Region Director, Treasurer or Legislative Consultant, or as committee chair for at least two yearsPlease Print or Type Name of Nominee: __________________________ Address:__________________________________ City/State/Zip: ______________________________ Phone: ___________________________________ Fax: ______________________________________ Email: ____________________________________

I, ______________________, agree to be nominated for President Elect and, if elected, agree to serve on the Executive Council of the American Society for Cytotechnology.Signature: ________________ Date: ____________________

Page 1 of 2ASCT





ASCT


www.asct.com


REGIONAL DIRECTOR OF ASCT for Regions 1, 3 and 5

Region 1: Alaska, California, Hawaii, Idaho, Montana, Oregon, Washington, Western Canada Region 3: Arkansas, Illinois, Indiana, Louisiana, Michigan, Mississippi, Ohio, Oklahoma, Texas) Region 5: Connecticut, Delaware, District of Columbia, Eastern Canada, Maine, Maryland, Massachusetts, New Hampshire, New Jersey, New York, Rhode Island, Vermont, Virginia Regional Directors are elected by the members of their region and serve a two-year term. The primary function of the Regional Director is to establish and maintain a line of communication between ASCT members and the Executive Council. In their role as Executive Council members, Regional Directors monitor regions for professional and legislative issues that may impact on cytotechnologists, give input to other Executive Council members on these and other issues, communicate pertinent information to members of their regions, prepare bi-monthly reports on the activities of their region, solicit and/or write articles for the Voice, participate and/or chair ASCT committees as necessary and represent ASCT at regional, state or national meetings. Attendance at the annual ASCT meeting is required. Please Print or Type Name of Nominee: __________________________ Region Number: ____________________________ Address:__________________________________ City/State/Zip: ______________________________ Phone: ___________________________________ Fax: ______________________________________ Email: ____________________________________

I, ______________________, from Region _______________agree to be Regional Director, if elected, agree to serve on the Executive Council of the American Society for Cytotechnology. Signature: ________________ Date: ____________________


Page 2 of 2ASCT








2006 Consensus Guidelines The 2006 Consensus Guidelines for the Management of Women with Abnormal Cervical Cancer Screening Tests the Management of Cervical Intraepithelial Neoplasia and Adenocarcinoma in situ* were published in the American Journal of Obstetrics and Gynecology (2007;197(4); 346-355) and are now available for review on the ASCCP website at http://www.asccp.org/consensus.shtml. Algorithms for the guidelines have been published in the ASCCP's October 2007 Journal of Lower Genital Tract Disease and are available in PDF format. Click here to download the PDF. http://www.asccp.org/consensus/cytological.shtml. To purchase reprints of the issue featuring the cytology guidelines with algorithms (JLGTD 2007;11(4):201-222), please visit www.jlgtd.com. Both the cytology and histology guidelines have also been reprinted in the October 2007 issue of the Journal of Lower Genital Tract Disease and only JLGTD carries the published algorithms.

Please note copyright in the line-by-line text of the Consensus Guidelines (cytology) belongs to Elsevier. Copyright in the Consensus Guidelines algorithms belongs to ASCCP. Permission to use the guidelines text requires the written permission of Elsevier. Permission to use the algorithms requires the written permission of ASCCP. To request permission for use of the algorithms, please follow the instructions. Note that no adaptations of the algorithms are permitted, including any changes in formatting (e.g., color, font, or style).


Page 1 of 2ASCT








Governor Signs Aanestad Medical Technology Bill

SB 366 Results in Improved Health Care for California Patients

SACRAMENTO: Senate Bill 366 authored by Senator Sam Aanestad (R-Grass Valley) was recently signed into law by Governor Schwarzenegger. The measure will continue to allow California laboratories to follow workload requirements established by the federal Clinical Laboratory Improvement Amendments (CLIA), when gynecologic slides are reviewed with the use of state-of-the-art equipment and processes to detect cervical cancer.

Congress passed CLIA in 1988, establishing quality standards for all non-research laboratory testing performed on specimens derived from humans for the purpose of providing information for the diagnosis, prevention, treatment of disease, or impairment of, or assessment of health. It established quality standards for laboratories to ensure the accuracy, reliability, and timeliness of patient test results regardless of where the test is performed.

“I’d like to thank this Governor for his support and understanding of advances in gynecological care that would not be available to a vast majority of Californians without SB 366,” said Senator Aanestad. “This new generation of testing, combined with automated imaging technology, results in increased accuracy in the diagnosis of precancerous lesions, as well as early stages of cervical cancer.”

Previous legislation authored by Senator Aanestad (SB 1355) conformed state law to federal law relating to workload requirements when using automated or semi-automated screening devices approved by the Food and Drug Administration (FDA). The provisions contained within SB 1355 will sunset at the end of this year. SB 366 will eliminate the sunset date and allow the new technology to continue to be used in California.

Gynecologic slides are normally reviewed by Cytotechnologists, who are specially trained clinical technologists that study human body cells. They examine cells to identify changes that may indicate diseases like cancer. Their duties include preparing microscope slides of cell samples, examining cell samples using microscopes, identifying abnormalities in shape, size, or color, using other automated lab equipment to perform tests, and analyzing report test results to physicians.

“My legislation allows these highly trained professionals to continue to use the best that technology has to offer when it comes to detecting serious health problems,” said Senator

Page 1 of 2ASCT





ASCT


www.asct.com


Aanestad. “Advancements in medical technology help save lives by detecting problems sooner than later, and I believe that Californians deserve the best that medical technology has to offer.”

SB 366 was sponsored by the CYTYC Corporation


Page 2 of 2ASCT


ASCT Page 1 of 8 · 2008. 12. 2. · For consideration, please forward your resume to: Cathy...

Documents

Transcript of ASCT Page 1 of 8 · 2008. 12. 2. · For consideration, please forward your resume to: Cathy...